Rachel Farley Loftus, MD
Dermatology · Cedar Grove, NJNPI 1285845941
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 32.4% of the total.
Across 201 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$927
- Pfizer$299
- Johnson & Johnson$268
- Lilly USA, LLC$263
- Incyte Corporation$188
- Sanofi$154
- plus $764 from 19 others
What the payments were for
- Food & beverage$2,863100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $927 |
| Pfizer | 20 | $299 |
| Johnson & Johnson | 19 | $268 |
| Lilly USA, LLC | 18 | $263 |
| Incyte Corporation | 13 | $188 |
| Sanofi | 10 | $154 |
| Galderma Laboratories, L.p. | 10 | $147 |
| Amgen | 9 | $147 |
| Sun Pharmaceutical Industries Inc. | 6 | $87 |
| Mayne Pharma Commercial LLC | 4 | $49 |
| Botanix SB Inc | 2 | $32 |
| Almirall LLC | 2 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $28 |
| LEO Pharma Inc. | 2 | $28 |
| Biofrontera Inc. | 2 | $27 |
| Novartis | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 2 | $25 |
| Dermavant Sciences, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,863 in reported general payments places this provider in the 55th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 12 | $669 |
| Fluorouracil | 11 | $590 |
| Triamcinolone Acetonide | 28 | $322 |
| CiclopiroxCiclopirox Olamine | 13 | $265 |
| Doxycycline Hyclate | 11 | $133 |
| Mupirocin | 18 | $94 |
| ValacyclovirValacyclovir Hcl | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cedar Grove
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
- Jason MillerFreehold$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.